Current Pharmaceutical Biotechnology SCIE
國際簡稱：CURR PHARM BIOTECHNO 參考譯名：當前的制藥生物技術(shù)
主要研究方向：醫(yī)學-生化與分子生物學 非預警期刊 審稿周期： 一般,3-6周
《當前的制藥生物技術(shù)》(Current Pharmaceutical Biotechnology)是一本由Bentham Science Publishers B.V.出版的以醫(yī)學-生化與分子生物學為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應用學科的最新發(fā)現(xiàn)，旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預警名單。
- 4區(qū) 中科院分區(qū)
- Q3 JCR分區(qū)
- 139 年發(fā)文量
- 2.2 IF影響因子
- 未開放 是否OA
- 73 H-index
- 2000 創(chuàng)刊年份
- Bimonthly 出版周期
- English 出版語言
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:
DNA/protein engineering and processing
Synthetic biotechnology
Omics (genomics, proteomics, metabolomics and systems biology)
Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
Drug delivery and targeting
Nanobiotechnology
Molecular pharmaceutics and molecular pharmacology
Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
Pharmacokinetics and pharmacodynamics
Applied Microbiology
Bioinformatics (computational biopharmaceutics and modeling)
Environmental biotechnology
Regenerative medicine (stem cells, tissue engineering and biomaterials)
Translational immunology (cell therapies, antibody engineering, xenotransplantation)
Industrial bioprocesses for drug production and development
Biosafety
Biotech ethics
Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
Current Pharmaceutical Biotechnology期刊信息
- ISSN：1389-2010
- 出版語言：English
- 是否OA：未開放
- E-ISSN：1873-4316
- 出版地區(qū)：UNITED STATES
- 是否預警：否
- 出版商：Bentham Science Publishers B.V.
- 出版周期：Bimonthly
- 創(chuàng)刊時間：2000
- 開源占比：0.0043
- Gold OA文章占比：0.66%
- OA被引用占比：0
- 出版國人文章占比：0.12
- 出版撤稿占比：0
- 研究類文章占比：38.13%
Current Pharmaceutical Biotechnology CiteScore評價數(shù)據(jù)（2024年最新版）
| CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||
| 5.6 | 0.492 | 0.547 |
|
名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量 注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。
Current Pharmaceutical Biotechnology中科院評價數(shù)據(jù)
中科院 2023年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 4區(qū) | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區(qū) 4區(qū) |
中科院 2022年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 4區(qū) | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區(qū) 4區(qū) |
中科院 2021年12月舊的升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 4區(qū) | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區(qū) 4區(qū) |
中科院 2021年12月基礎(chǔ)版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 4區(qū) | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區(qū) 4區(qū) |
中科院 2021年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 4區(qū) | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區(qū) 4區(qū) |
中科院 2020年12月舊的升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 4區(qū) | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 PHARMACOLOGY & PHARMACY 藥學 | 4區(qū) 4區(qū) |
Current Pharmaceutical Biotechnology JCR評價數(shù)據(jù)（2023-2024年最新版）
| 按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | 237 / 313 |
24.4% |
| 學科：PHARMACOLOGY & PHARMACY | SCIE | Q3 | 204 / 354 |
42.5% |
| 按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | 226 / 313 |
27.96% |
| 學科：PHARMACOLOGY & PHARMACY | SCIE | Q3 | 232 / 354 |
34.6% |
Current Pharmaceutical Biotechnology歷年數(shù)據(jù)統(tǒng)計
影響因子
中科院分區(qū)
Current Pharmaceutical Biotechnology中國學者發(fā)文選摘
-
1、The Role of VEGF Family in Lipid Metabolism
Author: Zhou, Yan; Zhu, Xueping; Wang, Huan; Duan, Chenglin; Cui, Hanming; Shi, Jingjing; Shi, Shuai; Yuan, Guozhen; Hu, Yuanhui
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 253-265. DOI: 10.2174/1389201023666220506105026
-
2、Distribution of Nicotinamide Mononucleotide after Intravenous Injection in Normal and Ischemic Stroke Mice
Author: Zheng, Si-Li; Wang, Dong-Sheng; Dong, Xin; Guan, Yun-Feng; Qi, Qi; Hu, Wen-Jun; Hong, Chen; Zhang, Chuan; Miao, Chao-Yu
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 299-309. DOI: 10.2174/1389201023666220518113219
-
3、Factors and Mechanisms Affecting the Secretion of Recombinant Protein in CHO Cells
Author: Yang, Yong-Xiao; Li, Qin; Li, Wei-Dong; Wang, Tian-Yun; Feng, Hui-Gen
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 391-400. DOI: 10.2174/1389201023666220603121316
-
4、Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer
Author: Xin, Rui; Shen, Biao; Huang, Zhong-Yan; Liu, Ji-Bin; Li, Sha; Jiang, Geng-Xi; Zhang, Jie; Cao, Ya-Hong; Zou, Da-Zhi; Li, Wen; Li, Chun-Guang; Ma, Yu-Shui; Fu, Da
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 427-437. DOI: 10.2174/1389201023666220818085945
-
5、Production of Recombinant Human Hybrid Ferritin with Heavy Chain and Light Chain in Escherichia coli and its Characterization
Author: Song, Xiaotong; Zheng, Yongxiang; Liu, Yongdong; Meng, Huan; Yu, Rong; Zhang, Chun
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 341-349. DOI: 10.2174/1389201023666220517225048
-
6、LTBP1 Gene Expression in the Cerebral Cortex and its Neuroprotective Mechanism in Mice with Postischemic Stroke Epilepsy
Author: Liu, Bo; Wang, Yan; He, Dongruo; Han, Guochao; Wang, Hao; Lin, Yuan; Zhang, Tianyu; Yi, Chao; Li, Hui
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 317-329. DOI: 10.2174/1389201023666220608091511
-
7、N-acetyl Cysteine Inhibits Cell Proliferation and Differentiation of LPS-Induced MC3T3-E1 Cells Via Regulating Inflammatory Cytokines
Author: Li, Wangyang; Zhang, Hui; Chen, Junchi; Tan, Yujie; Li, Ailing; Guo, Ling
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 450-459. DOI: 10.2174/1389201023666220520102001
-
8、Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma Cells by Promoting Apoptosis
Author: Li, Dan; Luo, Dongdong; Hu, Su; Zhao, Hailin; Peng, Biao
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 310-316. DOI: 10.2174/1389201023666220513100129
Current Pharmaceutical Biotechnology同類期刊
-
公共衛(wèi)生前沿
Frontiers In Public Health
中科院 3區(qū) JCR Q2
-
藥理學前沿
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
-
生物醫(yī)學與藥物治療
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
-
探索腫瘤學
Discover Oncology
中科院 4區(qū) JCR Q2
-
Bmc精神病學
Bmc Psychiatry
中科院 2區(qū) JCR Q2
-
Bmc神經(jīng)病學
Bmc Neurology
中科院 3區(qū) JCR Q3
-
材料化學雜志 B
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
-
美康
Medcomm
中科院 3區(qū) JCR Q1
免責聲明
若用戶需要出版服務，請聯(lián)系出版商：BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。